# Iterion Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iterion-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Houston, US
- Website: www.iteriontherapeutics.com
- Total disclosed funding: $24M
- Latest round: Series B (Feb 16, 2021)
- Investors on record: 5

## About

Founded in 2010 and based in Houston, Texas, Iterion Therapeutics, trading under the name Betacat Pharmaceuticals, Inc., operates as a biopharmaceutical company that develops novel targeted cancer therapeutics designed to treat a person with cancer. The company was co-founded by Rahul Aras, Steve Horrigan, and Sunil Sharma, and in February 2021, Iterion Therapeutics Inc. and Apollomics, Inc. announced an exclusive collaboration and license agreement to develop and commercialize tegavivint in Greater China. In February 2021,  the company received USD 17 million in Series B funding from Lumira Venture, Santé Ventures, Venture Investors, GPG Ventures, and Viva BioInnovator.

The company offers a cancer treatment called "Tegavivint" a beta-catenin and Wnt gene expression modulator that prevents cancer gene activation and maintains regular tissue function. The company's product also provides anti-tumor activity in multiple pre-clinical models, including acute myeloid leukemia (AML) and non-small cell lung cancer (NSCLC).

Apollomics, Inc. and Iterion Therapeutics Inc. plans to expand clinical development for a potent and selective small-molecule targeting TBL1, a downstream target in the Wnt/ß-catenin signaling pathway.

## Funding rounds

- Series B, Feb 16, 2021, $17M — Venture Investors, Sante Ventures, Green Park & Golf Ventures, Viva BioInnovator, Lumira Ventures
- Series B, Jul 25, 2016, $5M — Sante Ventures
- Series A, Jun 19, 2015, $2M — Sante Ventures

## Investors

- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Series A, Series B
- Venture Investors — Series B
- Green Park & Golf Ventures (https://capitalatlas.ai/funds/green-park-golf-ventures) — Series B
- Viva BioInnovator (https://capitalatlas.ai/funds/viva-bioinnovator) — Series B
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series B